Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 06, 2015 7:39 PM ET

Biotechnology

Company Overview of Eleven Biotherapeutics, Inc.

Key Executives for Eleven Biotherapeutics, Inc.

NameBoard RelationshipsTitleAge
Abbie C. Celniker Ph.D.34 RelationshipsChief Executive Officer, President and Director55
Reza Dana M.D., MPH,M.Sc36 RelationshipsFounder--
K. Christopher Garcia Ph.D.No RelationshipsCo-Founder--
Gregory L. Verdine Ph.D.33 RelationshipsCo-Founder55
Casey T. Weaver M.D.No RelationshipsCo-Founder--
View More Key Executives

Eleven Biotherapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Daniel S. Lynch M.B.A 91 RelationshipsBlueprint Medicines Corporation56
Abbie C. Celniker Ph.D. 34 RelationshipsEleven Biotherapeutics, Inc.55
Jane Pritchett V. Henderson 8 RelationshipsKolltan Pharmaceuticals, Inc.48
David A. Berry M.D., Ph.D. 54 RelationshipsSeres Health, Inc.36
Cary G. Pfeffer M.D. 25 RelationshipsThird Rock Ventures, LLC52
View All Board Members

Eleven Biotherapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Jane Pritchett V. Henderson8 Relationships3 Executives
Compensation Committee M.B.ADaniel S. Lynch91 Relationships3 Executives
Nominating Committee M.B.ADaniel S. Lynch91 Relationships3 Executives
Corporate Governance Committee M.B.ADaniel S. Lynch91 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$393.8K
393.8K
395.8K
Bonus$177.2K
177.2K
244.3K
Total Short Term Compensation
Not meaningful
Total Value of Options$570.9K
570.9K
32.2M
Compensation as of Fiscal Year 2014
Eleven Biotherapeutics, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Monica Nassif Joins Aunt Fannie's Board of Directors
May 05, 2015 1:32 PM ET
SCA Announces Resignation of Rolf Börjesson as Member of the Board of Directors
May 04, 2015 5:57 AM ET
Energizer Holdings Inc. Announce Composition of New Boards of Directors
April 27, 2015 9:00 PM ET
Anders Nyrén to Leave His Assignment as Member of SCA Board of Directors as of April 30, 2015
April 27, 2015 5:58 AM ET
The Clorox Company Announces Retirement of Daniel Boggan as Directors, Effective May 13, 2015
April 24, 2015 9:00 PM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Eleven Biotherapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.